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 INTRODUCTION 
 Aedes aegypti 1, 2 and  Aedes albopictu 3, 4 are important vectors 
of dengue and chikungunya viruses. Both species breed in arti-
ficial containers, often in small items such as buckets and plas-
tic food containers that hold less than 5 L of water. Dengue 
control programs often do not have the resources or personnel 
to revisit properties and treat containers at frequent intervals. 
Thus, residual larvicides are needed to control mosquitoes in 
small ground containers when removal of the containers is not 
possible. Several products offer residual control of  Ae. aegypti 
including the insect growth regulators (IGRs) s-methoprene 5 
and pyriproxyfen, 6 the chitin synthesis inhibitors triflumuron 7 
and novaluron, 8 and the organophosphate temephos 9 and 
synthetic pyrethroid insecticides. 10 However, IGR efficacy is 
difficult to assess and requires collection of pupae to assess 
emergence inhibition. Resistance has developed to both teme-
phos 11 and synthetic pyrethroids 12 in  Ae. aegypti , and insecti-
cides can also have significant nontarget effects. 
 Bacillus thuringiensis var.  israelensis (Bti) is a bacterial 
agent that kills mosquito larvae when ingested. Generally, it 
is used for broad acreage and small plot treatment, with lit-
tle persistence in the environment. 13 Indeed, the label rates 
are based on bioassays and field trials with 24-hr mortality 
as a key measure. Thus, the rates are not designed for resid-
ual treatment. However, some studies indicate that residual 
efficacy lasting up to 16 weeks can occur in containerized 
water, 14 especially when higher doses are used. Indeed, some 
higher rates (in excess of 100,000 international toxic units; 
ITUs/L) have been used. 15, 16 Tablet formulations have been 
developed that provide several weeks control of  Ae. aegypti 
in water storage containers. Armengol and others. 17 found 
that a 4.8% technical powder Bti tablet provided 12 weeks of 
> 80% reduction in pupae production within 70-L containers 
exposed to sunlight. Use of VectoBac DT (dispersible tablet) 
significantly reduced pupal numbers in large cement jars for 
up to 3 months. 18 Benjamin and others 19 obtained > 90% con-
trol of  Ae. aegypti in earthenware jars for up to 5.5 months 
using VectoBac DT. Granular formulations of Bti have been 
used to control  Ae. aegypti in tires for up to 33 days, 9 and 
wettable powder and tablet Bti formulations provided 80% 
control for up to 6 months. 20 
 VectoBac WG (water dispersible granule; WG) has a potency 
of 3,000 international toxic units (ITU)/mg for  Ae. aegypti 
and is especially suited for control of  Ae. aegypti in containers. 
This is the only Bti formulation evaluated and specifications 
published by the World Health Organization (WHO, 2007). 21 
Vilarinhos and Monnerat 22 found that a dose of 4 mg/L of 
VectoBac WDG (equivalent to Vectobac WG) provided 
> 90% control of  Ae. aegypti in 250-L fiberglass jars for up to 
12 weeks when the trial was terminated. However, Lima and 
others 23 only obtained 9–36 days control, but this was in 50-L 
jars treated at a rate of only 2 mg/L. Lee and Zairi 24 found 
that application of VectoBac ABG6561 (i.e., VectoBac WG) at 
5 mg/L (15,000 ITU/L) provided > 90% control of  Ae. aegypti 
for 49 and 56 days, respectively, in ceramic jars and glass jars. 
Subsequent field trials showed that using 2 mg/L VectoBac 
WG (6,000 ITU/L) decreased  Ae. aegypti production by > 90% 
for 35 to 40 days in both container types. 25 
 The WD formulation readily suspends in the water column 26 
and gradually settles to the base of the container where it is 
ingested by larvae. 27 Only a very small dose is required for 
small to medium sized (< 20 L capacity) containers. Indeed, 
using a recommended rate of 8 g/1,000 L (Benjamin S, Valent 
Biosciences, personal communication), a typical 1-L container 
would only require 8 mg of product (24,000 ITU/L). These 
minute amounts are impractical to measure in the field for the 
treatment of individual containers. Thus, it is possible that by 
using high doses of product (“megadoses”), practicality could 
be improved while extending efficacy to several months. The 
excellent dispersive qualities of the WG formulation may also 
allow us to treat flooded containers by simply adding dry for-
mulation. 26 This would greatly improve the speed and logis-
tics of treating containers during dengue control operations as 
water will not have to be carried and dosages mixed by field 
staff. 
 Initially, we conducted a small trial to see if simple appli-
cation of dry VectoBac WG to the water gave comparable 
results as treatment using an aqueous solution. From this, a 
large field trial using “megadoses” of 10×, 20×, and 50×, the 
recommended manufacturer’s rate of 8 mg/L, were conducted 
against  Ae. aegypti . In many field situations containers are dry, 
and workers need a product that can be used to reliably “pre-
treat” dry containers for up to 1–2 months. We also measured 
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the efficacy of VectoBac WG in buckets that were not flooded 
for 1 and 2 months. 
 MATERIALS AND METHODS 
 Will a dry dose of VectoBac WG provide comparable 
control as an aqueous solution?  A standard dose of 16 mg of 
VectoBac WG was mixed with 100 mL of water and sprayed 
to runoff inside a 2-L white plastic bucket creating a dose of 
8 mg/L (24,000 ITU/L). We also applied the same amount 
of dry formulation to a 2-L bucket containing 2 L of water. 
An untreated bucket served as a control. Five longan tree 
( Dimocarpus longan Lour.) leaflets were added to each bucket 
to provide natural organic matter. Each week, 10 second instar 
 Ae. aegypti (F 2–5 Cairns strain) were added to each bucket and 
24-hr mortality determined. Five replicates were conducted, 
and each bucket was placed into a crate that was covered 
with fine cloth mesh to prevent oviposition by mosquitoes 
( Figure 1 ). Alfalfa pellets (rabbit chow) were provided  ad 
libitum as larval food. The crates were placed under a veranda 
to provide shade but were exposed to rain. The trial was 
continued until treatment mortality was < 80%. 
 Can a megadose of VectoBac WG provide residual control 
of  Ae. aegypti ?  A similar exposure method used in the 
formulation trial was used. The crates were placed outside in 
a well-shaded area under a mango ( Magnifera indica L.) tree 
but were exposed to rainfall. The dry treatment method was 
used in the following treatments: 
 1.  untreated control; 
 2.  dose of 80 mg/L (240,000 ITU/L) unmixed VectoBac WG/
container (10× recommended rate); 
 3.  dose of 160 mg/L (480,000 ITU/L) unmixed VectoBac WG/
container (20× recommended rate); and 
 4.  dose of 400 mg/L (1,200,000 ITUs/L) unmixed VectoBac 
WG/container (50× recommended rate). 
 Doses of VectoBac WG were weighed on a balance (pre-
cision of 0.001) and then immediately sprinkled into the test 
bucket. There were five replicates and the trial was run for 
33 weeks from March 25 to November 11, 2007. Rainfall at the 
site was measured using a rain gauge, and temperature from a 
Bureau of Meteorology station located 5 km away. 
 Each week, 20 third instar  Ae. aegypti (Cairns strain, F2–F8) 
were added to each bucket. The 0.5 g of alfalfa was added for 
food when needed. Larval mortality was determined at 24 hr, 
and all pupae were collected within 3 to 5 days of exposure. 
Pupae were placed in 70-mL jars and percent emergence inhi-
bition determined and used to calculate overall (total) mortal-
ity of each treatment cohort. For each Bti treatment, efficacy 
was assessed until control was less than 50% for two consecu-
tive weeks. Efficacy was assessed every 2 weeks after Week 22 
for the 50× dose. An analysis of variance (ANOVA) (SPSS, Inc., 
version 14, Chicago, IL) was used to compare treatment means 
for each week, with Tukey’s honestly significant difference 
(HSD) used to separate means at  P < 0.05 level . An unpaired 
t  test was used to compare the number of larvae surviving 24-hr 
post treatment and the overall mortality for each dose. 
 Pretreatment of dry containers using VectoBac WG for 
residual control of  Aedes aegypti.  The efficacy of VectoBac 
WG as a pretreatment was tested for small containers against 
 Ae. aegypti for 0, 4, and 8 weeks before the containers were 
flooded with 2 L of water. Pretreatment exposure was 
undertaken in a covered carport to prevent flooding by rainfall, 
but allowed exposure to prevailing ambient temperatures. Two 
doses were used, a 1× and 10× manufacturers’ recommended 
rate (8 and 80 mg/L, respectively = 16 and 160 mg in each 2-L 
bucket). Furthermore, untreated buckets were included in 
the experimental design as a Bti control. For each treatment 
five replicates were undertaken. After the completion of 
pretreatment exposure each test bucket was flooded with 2 L 
of water and the crates of buckets were placed in an outdoor 
shaded area that was exposed to rainfall. Longan leaflets were 
added as with the previous trial. Test buckets were “challenged” 
each week, starting on the day buckets were flooded with 10 
third instar  Ae. aegypti larvae. Mortality was assessed 24 hr 
after larvae had been introduced into the test buckets and 
again at adult emergence (overall mortality). Both 24 hr 
and overall mortality were monitored until overall mortality 
in each bucket for a given treatment was < 50% for two 
consecutive weeks. Rainfall and temperature were recorded 
as in previous trials. The trial was conducted for 11 weeks from 
December 5, 2007 to February 20, 2008. A one-way ANOVA 
and Tukey’s HSD were used to separate treatment effects for 
 Figure 1 .  Experimental buckets containing 2 L of water and lon-
gan leaflets were held in crates in an outdoor shaded environment 
exposed to rainfall. Mesh screening was used to prevent oviposition 
by wild mosquitoes. 
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overall mortality each week after buckets had been flooded. 
We used an unpaired  t test to compare the 24 hr survival and 
overall mortality between 1× and 10× treatments. 
 RESULTS 
 Will a dry dose of VectoBac WG provide comparable control 
as an aqueous solution?   The wet and dry application treatments 
provided excellent control for up to 3 weeks post treatment 
( Figure 2 ), despite nearly 1 m (952 mm) of rain during the 
trial (28 Jan–4 Mar 2007). There was no significant difference 
( t test,  P > 0.05) between mortality of the wet and dry treatments 
for each of the five exposures. Beyond 3 weeks post treatment, 
dry application provided about 20% higher mortality than 
wet application, although this was not significantly higher 
( t = 1.25,  P = 0.22). Mean control mortality was only 6%. These 
data indicate that a simple direct application of dry VectoBac 
WG to containers will provide comparable control as an 
aqueous mixture. The direct dry application was used to test 
the megadoses. 
 Can a megadose of VectoBac WG provide residual control 
of  Ae. aegypti ?  Megadoses of VectoBac WG provided 
persistent control of  Ae. aegypti in the buckets. A total of 
377 mm of rainfall fell during this trial. The 10×, 20×, and 
50× treatments provided at least 100% control for 7, 7, and 
22 weeks, respectively ( Figure 3 ;  Table 1 ). Interestingly, after 
week 13 some larvae exposed to the 50× dose survived 24-hr 
post-exposure but died before pupating. Overall, mortality 
was significantly greater than 24-hr mortality for the 20× ( t = 
2.28,  P = 0.02) and 50× ( t = 2.15,  P = 0.03) doses but not for 
the 10× dose ( t = 0.96,  P = 0.34). Thus, 24-hr larval mortality 
underestimates actual mortality. We also found there was 
 Figure 2 .  Mean (±SE) percent 24-hr mortality of second instar  Ae. 
aegypti larvae exposed to dry and wet formulations of VectoBac WG 
applied at 8 mg/L. 
 Figure 3 .  Mean (±SE) percentage 24 hr and overall mortality (through adult emergence) of  Aedes aegypti third instar larvae exposed to 8, 16, 
and 40 mg/L of VectoBac WG in an outdoor container trial. 
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little impact on pupal emergence ( Table 2 ), with a very high 
percentage of adults successfully eclosing in all treatments. 
 Pretreatment of dry containers.  The manufacturer’s recom-
mended rate of 8 mg/L (1× dose) VectoBac WG was a very 
effective pretreatment of the control  Ae. aegypti regardless of 
whether the test bucket was treated 0, 4, or 8 weeks before 
the bucket was flooded ( Figure 4 ;  Table 3 ). Mortality (both 
24 and overall) was significantly higher than the control for at 
least 7 weeks for all pretreatment periods ( Figure 4 ;  Table 3 ). 
For all pretreatment periods the 1× dose provided 100% 
overall mortality for 6 weeks. The only significant difference 
in mortality to  Ae. aegypti larvae among the three pretreat-
ments lengths occurred after 8 weeks when pretreatment of 
4 weeks produced significantly lower overall mortality than a 
pretreatment of 0 or 8 weeks ( Figure 4B ). 
 The high dose (80 mg/L) also proved effective over the 
extended pretreatment period ( Figure 5 ,  Table 4 ). There was 
no significant difference in 24 hr and overall larval mortal-
ity between the 0, 4, and 8 week pretreatment until Weeks 10 
and 12, respectively. The 80 mg/L dose provided greater effi-
cacy than the 8 mg/L dose against third instar  Ae. aegypti over 
the three pretreatment periods ( Figures 4 and  5 ). Mortality 
(24 hr) for pretreatment periods of 0 ( t = 4.68,  P < 0.001), 
4 ( t = 4.37,  P < 0.001), and 8 ( t = 2.40,  P < 0.018) weeks was 
significantly higher for the 80 mg/L dose. Overall, mortality 
was significantly higher for pretreatment periods 0 ( t = 4.66, 
 P < 0.001) and 4 ( t = 3.72,  P < 0.001) weeks but not for 8 weeks 
( t = 1.40,  P = 0.16). The 10× dose provided 100% mortality for 
7 weeks for all pretreatment lengths and the 0 pretreatment 
period was still providing significantly greater overall mortal-
ity compared with the untreated control 14 weeks after con-
tainers had been flooded. Similar to the 1× dose the residual 
effect of the 10× dose was not greatly influenced by the length 
of pretreatment, although there was some evidence that a pre-
treatment of 0 weeks caused higher 24 hr and overall mortality 
10 to 12 weeks after buckets were flooded. Indeed, 13 weeks 
 Table 1 
 The effect of 10×, 20×, and 50× recommended dose (8 mg/L) treatments of VectoBac WG on (a) 24-hr mortality, and (b) overall mortality (until 
adult emergence) of third instar  Aedes aegypti in 2-L buckets * 
(a)
Week 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 24 26 28 30
 P value 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.01 0.02 0.22 0.35
Control a a a a a a a a a a a a a a a a a a a
10× dose b b b ab a a a a – – – – – – – – – – –
20× dose b b b bc b a b b a a a a a a a – – – –
50× dose b b b c b b c c b b b b b b b b b a a
(b)
Week 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 24 26 28 30
 P value 0 0 0 0.02 0 0 0 0 0 0 0 0 0 0 0 0 0.01 0.09 0.21
Control a a a a a a a a a a a a a a a a a a a
10× dose b b b ab ab a a a – – – – – – – – – – –
20× dose b b b b bc b b b b b a a a a a – – – –
50× dose b b b b c c c b c c b b b b b b b a a
 *  Means analyzed using a one-way analysis of variance and significantly different treatments were identified using Tukey’s HSD post-hoc test;  P < 0.05. Treatment means in the same row with the 
same letter were not significantly different; – infers treatment ceased. 
 Table 2 
 Percent emergence of  Aedes aegypti pupae developed from lar-
vae exposed to 10×, 20×, and 50× label rate (8 mg/L) treatment of 
VectoBac WG over different lengths of exposure 
Control 
(30 weeks)
10× Dose 
(15 weeks)
20× Dose 
(22 weeks)
50× Dose
(30 weeks)
Pupae picked 896 220 366 136
Adults emerged 890 215 360 135
% Emergence 99.3% 97.7% 98.4% 99.3%
 Figure 4 .  Percentage 24-hr mortality and overall mortality of 
 Aedes aegypti third instar larvae provided by the pretreatment of test 
buckets with standard rate of VectoBac WG (8 mg/L) 0, 4, and 8 weeks 
before buckets were flooded. 
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after buckets were flooded the pretreatment of 0 weeks 
provided significantly higher 24 hr and overall mortality 
( Figure 5 ;  Table 4B ) compared with the pretreatments of either 
4 or 8 weeks in length. 
 DISCUSSION 
 We have showed that a dry dispersible granule Bti formula-
tion (VectoBac WG) can be used to provide residual control of 
 Ae. aegypti in small ground containers. Megadose Bti applica-
tion is intended for situations where discarded containers such 
as buckets and tires, rather than water storage containers (e.g., 
drums, jars, and tanks), are a key container for  Aedes . Many 
tropical urban areas subject to dengue outbreaks (e.g., North 
Queensland, Singapore) have piped water supply, and do not 
store water in large containers. In these areas, small ground 
containers such as tires, buckets, ornamental plant bowls, and 
vases are important producers of  Ae. aegypti . 28 
 Our results do reflect semi-field conditions, and have greater 
validity than laboratory assays. The containers were exposed to 
rainfall, ambient temperature fluctuations, and longan leaflets 
were added to the buckets to simulate accumulation of detri-
tus. However, the screening and location of the crates in deep 
shade would have minimized exposure to UV light, which can 
reduce efficacy of Bti. 23 It is likely that efficacy in containers 
exposed to partial or full sunlight would not be as persistent. 
When used in an operational situation VectoBac WG may be 
subjected to higher temperatures, increased sunlight, and more 
cyclical flooding and drying compared with those recorded in 
the current study. How these environmental variables affect 
its larvicidal persistence is unknown. If they cause a reduction 
in efficacy vector control, officers will require training with 
regards to the most appropriate application sites (i.e., shaded) 
for VectoBac WG in the field. 
 The formulation trial showed that VectoBac WG can be 
applied directly to flooded containers with no loss of efficacy. 
The WG formulation rapidly spreads across the water surface 
before gradually sinking. We suspect that most Bti endospores 
and crystals become attached to the sides and bottom of the 
bucket where they are ingested by grazing  Ae. aegypti larvae, 
as confirmed by Su and Mulla. 27 Indeed, larvae were still killed 
in one bucket after the water was tipped out and the bucket 
rinsed. Benjamin and others 19 and Lee and Zairi 25 describe a 
similar situation where replenishing water in large earthen 
(ceramic) jars and 2-L glass jars did not significantly reduce effi-
cacy against  Ae. aegypti. Megadoses of VectoBac WG provided 
 Table 3 
 Treatment effects for (a) 24-hr mortality, and (b) overall mortality (until adult emergence) of third instar  Aedes aegypti in 2-L buckets pretreated 0, 
4, and 8 weeks before flooding with 8 mg/L VectoBac WG * 
(a)
Week 1 2 3 4 5 6 7 8 9 10 11 12
 P value 0 0 0 0 0 0 0 0 0.10 0.59 0.55 0.29
Control a a a a a a a a a a a a
0 weeks b b b b b b b b a a a a
4 weeks b b b b b b b a a a a a
8 weeks b b b b b b b b a a a a
(b)
Week 1 2 3 4 5 6 7 8 9 10 11 12
 P value 0 0 0 0 0 0 0 0 0.05 0.01 0.33 0.19
Control a a a a a a a a a a a a
0 weeks b b b b b b b b a b a a
4 weeks b b b b b b b a a ab a a
8 weeks b b b b b b b b a b a a
 *  Data ( Figure 4 ) analyzed with a one-way analysis of variance. Significantly different pretreatment lengths were identified using Tukey’s HSD post-hoc test and have been identified with a 
different letter ( P < 0.05). 
 Figure 5 .  Percentage 24 hr and overall mortality of  Aedes aegypti 
third instar larvae provided by the pretreatment of test buckets 
with VectoBac WG (80 mg/L) 0, 4, and 8 weeks before buckets were 
flooded. 
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residual control of  Ae. aegypti for several months even in 
heavy rain. No pupal emergence inhibition was noted. The 
persistence of control may also be linked to recycling of Bti 
toxins; perhaps as cadavers are ingested. 20 Furthermore, vari-
ability in mortality as efficacy declines was noted. This may 
be caused by the increasing stochastic processes involved with 
the interception and ingestion of a declining number of lethal 
Bti crystals and spores by grazing larvae. 
 We also showed that VectoBac WG can be used as a reli-
able pretreatment of dry containers for at least 8 weeks before 
the container is flooded with little reduction in larvicidal effi-
cacy. Operationally, this means that vector control officers can 
treat dry containers in the field knowing that if the container 
is flooded sometime in the next 1–2 months mosquito mortal-
ity will be as effective within the container as would have been 
achieved by treating the container at the time of flooding. 
A higher dose provides longer residual control. 
 Environmental factors could also impact the efficacy of dry 
Bti used as a pretreatment of dry containers. For instance, effi-
cacy may be affected by multiple flooding and drying events 
within a container. Furthermore, although containers exposed 
to direct sunlight in the field are not preferred oviposition sites 
for dengue vectors, a trial to determine the impact of vary-
ing amounts of sunlight on efficacy may be of value. We have 
showed that the persistence of VectoBac WG increases when 
it is used as a pretreatment “mega-dose” of 80 mg/L versus 
8 mg/L ( Figures 4 and  5 ). Thus, the manufacturer’s recom-
mended rate may need to be changed for use against container 
breeding mosquitoes in non-potable water. Operationally, dry 
Vectobac WG can be applied from a 275-mL plastic sauce bot-
tle. By tipping the bottle upside down approximately 100 mg 
of product is released through the nozzle; squeezing the bottle 
increases this to 300–400 mg (Davis J, unpublished data). Finally, 
tablet formulations may be even easier to apply in the field and 
should be considered for use in large ground containers. 
 Is the use of megadoses of dry formulations of Bti cost-
effective for dengue control? Certainly use of megadoses of 
Bti would be prohibitively expensive where very large con-
tainers such as a 1,000-L tank, treated at 0.4 g/L, requires 400 g 
of product! However, for treatment of small to medium sized 
ground containers that hold < 20 L of water, it is potentially 
cost-effective. During container surveys in Cairns, Australia 
during an epidemic of DENV-3 in 2009, premise yards ( N = 
29,841) had an average of 1.64 small to medium sized con-
tainers, with an average capacity of 1.3 L per container 
(Queensland Health, unpublished data). Treating these with 
a 50× dose (0.4 g/L) would cost $AUS0.03 per container or 
$AUS0.05 per yard, based on a retail price of $AUS900 for 
a 25-kg container of VectoBac WG. A two person team can 
typically inspect 50 premises/day, treating an average of 80 
containers at a material cost of $AUS2.42 (US$2.18) per day. 
This could potentially provide > 90% control of  Ae. aegypti for 
up to 22 weeks ( Figure 3 ). Pupal surveys in Merida, Mexico 
revealed that small to medium sized containers accounted for 
87% of  Ae. aegypti pupae, with a mean of 4.2 wet containers/
premise. 29 Thus, the estimated cost to treat 50 yards is US$5.72. 
Further trials should be conducted to confirm efficacy and cost 
effectiveness of Bti megadose interventions under operational 
field conditions. 
 Finally, there is legal precedent for registering of prod-
ucts for megadose use in nonpotable water within containers 
for residual control of mosquitoes. The Australian label for 
Prolink Pellets (4% s-methoprene) states “ProLink Pellets 
may be used in artificial containers, which breed mosquitoes, 
such as water tanks, plant pot holders, tyres, gutters, and catch 
basins, and in ornamental plants such as bromeliads. For resid-
ual treatment of water in small containers or wet areas, the 
following is recommended: 1 pellet/L or m 2 for control up to 
3 months; 3 pellets/L or m 2 for control up to 6 months.” Thus, 
it is hoped that a similar strategy could be developed for Bti 
use against container-breeding mosquitoes such as  Ae. aegypti 
and  Ae. albopictus . 
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